In meeting with Malaysian PM, Modi raises issue of Dr Zakir Naik’s extradition

Mangaluru, Apr 3: The laboratory at District Wenlock Hospital has initiated trial for Covid 19 testing, close on the heels of receiving permission from state government.

Doctors, elected representatives and stakeholders had repeatedly demanded that a laboratory should be set up in the port city. Without the lab, the samples were sent either to Shivamogga or to Bengaluru for testing. When Heath Minister Sriramulu had visited Mangaluru on March 17, he had promised a lab in the city for testing of the samples.

Accordingly, the government gave permission for starting the laboratory at Wenlock Hospital. The process of registering the lab with Indian Council for Medical Research (ICMR) will be completed shortly. The laboratory will be fully operational only after it is registered.

Bengaluru, May 29: Karnataka reported 248 new cases of coronavirus on Friday, and with that, the state tally surged to 2,781. 

A 50-year-old woman, resident of Chikkaballapura district, succumbed to the infection on Friday. She was admitted to a private hospital on May 24 following acute kidney injury and pneumonia. As her condition deterorted, she was shifted to a designated hospital in Bengaluru Urban on May 28, where she tested COVID-19 positive.

Out of the 248 cases, only 16 persons have contracted the virus inside the state. The remaining are the people who have returned from Maharashtra, Delhi, Andhra Pradesh, Tamil Nadu and Ireland.

The maximum number of people, who tested positive for COVID-19, have returned from Maharashtra. Most of these people are residents of Udupi, Kalaburagi, Yadagiri and Raichuru.

Besides, five people have a travel history to Delhi, while one person each has tested positive on returning from Andhra Pradesh, Tamil Nadu, Rajasthan and Ireland.

Fifteen people have tested positive within the state and have been infected by persons who had previously tested positive or have a history of Influenza-like Illness and Severe Acute Respiratory Illness.

Out of all the cases, 10 have been reported in Bengaluru Urban while one has come up in Bengaluru Rural.

Meanwhile, on Thursday, the Karnataka government asked the Civil Aviation Ministry to reduce the number of flights coming in the state from the five worst-hit states -- Maharashtra, Tamil Nadu, Gujarat, Madhya Pradesh and Rajasthan.

"Karnataka has appealed to the Civil Aviation Ministry to take steps to lessen the air traffic to the state, with the sacred intention that there may not be adequate quarantine facilities if there is a huge turnout in a short span of time," state Law and Parliamentary Affairs Minister J.C. Madhuswamy explained.

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.